PF-AtlasDrugs › taladegib

taladegib

Idiopathic Pulmonary Fibrosis

Clinical trials
2
Developer
Endeavor Biomedicines, Inc.

Overview

taladegib is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.

taladegib clinical trials

Explore related

Medical disclaimer. This page summarizes research about taladegib for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.